Liraglutide Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Liraglutide Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 07/18/2023.
Shortage Details
- Status
- Current
- Company
- Hikma Pharmaceuticals USA, Inc.
- Package NDC
- 0143-9144-02
- Dosage Form
- Injection
- Presentation
- Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-02)
- Initial Posting
- 07/18/2023
- Revised Date